Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fecal Microbiota Transplantation/adverse effects"'
Autor:
Halkjær, Sofie Ingdam, Lo, Bobby, Cold, Frederik, Højer Christensen, Alice, Holster, Savanne, König, Julia, Brummer, Robert Jan, Aroniadis, Olga C., Lahtinen, Perttu, Holvoet, Tom, Gluud, Lise Lotte, Petersen, Andreas Munk
Publikováno v:
Halkjær, S I, Lo, B, Cold, F, Højer Christensen, A, Holster, S, König, J, Brummer, R J, Aroniadis, O C, Lahtinen, P, Holvoet, T, Gluud, L L & Petersen, A M 2023, ' Fecal microbiota transplantation for the treatment of irritable bowel syndrome : A systematic review and meta-analysis ', World Journal of Gastroenterology, vol. 29, no. 20, pp. 3185-3202 . https://doi.org/10.3748/wjg.v29.i20.3185
BACKGROUND: Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in developed countries and reduces patients' quality of life, hinders their ability to work, and increases health care costs. A growing number of trials have d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea43b4b38ab53f0ddc89071f99e6a36
https://curis.ku.dk/ws/files/359318091/WJG_29_3185.pdf
https://curis.ku.dk/ws/files/359318091/WJG_29_3185.pdf
Autor:
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Publikováno v:
Holmstroem, R B, Dahl, E K, Helms, M, Nielsen, H V, Andersen, J B, Bjerrum, J T, Svane, I M, Ellebaek, E & Seidelin, J B 2022, ' Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis : case report ', BMJ Open Gastroenterology, vol. 9, no. 1, e000989 . https://doi.org/10.1136/bmjgast-2022-000989
BackgroundImmune checkpoint inhibitors (ICIs) can induce a wide range of immune-related adverse events (irAEs), potentially affecting any organ. ICI-induced colitis is a frequently reported irAE, whereas enteritis is rare and not well documented.Case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c058cd1452d0daf71f568c62b551a9
https://curis.ku.dk/portal/da/publications/tofacitinib-and-faecal-microbiota-transplantation-in-treating-checkpoint-inhibitorinduced-enterocolitis(9a254421-b5ef-4cb4-83ad-938ac9ad0619).html
https://curis.ku.dk/portal/da/publications/tofacitinib-and-faecal-microbiota-transplantation-in-treating-checkpoint-inhibitorinduced-enterocolitis(9a254421-b5ef-4cb4-83ad-938ac9ad0619).html
Autor:
Camilla Kara Svensson, Frederik Cold, Iben Ribberholt, Mike Zangenberg, Hengameh Chloé Mirsepasi-Lauridsen, Andreas Munk Petersen, Morten Helms
Publikováno v:
Svensson, C K, Cold, F, Ribberholt, I, Zangenberg, M, Mirsepasi-Lauridsen, H C, Petersen, A M & Helms, M 2022, ' The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection : A Retrospective Cohort Study. ', Cells, vol. 11, no. 20, 3272 . https://doi.org/10.3390/cells11203272
Cells; Volume 11; Issue 20; Pages: 3272
Cells; Volume 11; Issue 20; Pages: 3272
The most effective treatment for recurrent Clostridioides difficile infection (CDI) is faecal microbiota transplantation (FMT); however, the optimal route of administration is thus far unknown. This retrospective cohort study of 343 patients sought t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c26bceda81ef6b22dbfee303711143e
https://curis.ku.dk/ws/files/323977049/cells_11_03272.pdf
https://curis.ku.dk/ws/files/323977049/cells_11_03272.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.